首页> 外文期刊>Journal of Surgical Oncology >Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
【24h】

Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.

机译:DNA倍性模式,S期分数(SPF)和增殖性细胞核抗原(PCNA)对原发性胃淋巴瘤患者的预后影响。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: DNA ploidy, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) are considered to be significant prognostic factors in non-Hodgkin lymphomas. However, reports on their prognostic importance in gastric lymphoma patients are relatively lacking. METHODS: In the present study, we retrospectively studied the above-mentioned parameters in 29 patients with primary gastric lymphoma; 11/29 had B-low grade mucosa associated lymphoid tissue lymphoma (B-MALT), while 18/29 had diffuse large B-cell lymphoma (DLBCL), according to WHO classification. Proliferative activity was studied by staining against PCNA; in addition, the prognostic significance of DNA ploidy and SPF, as determined by flow cytometry, were investigated and compared to the results of the PCNA stainings. RESULTS: Seven out of 29 patients were found to have aneuploid tumors; DNA index values were >1 for all aneuploid lymphomas. There was no difference in DNA aneuploidy in MALT vs. DLBCL. The mean percentage of SPF was 11.4. SPF was found significantly lower in MALT vs. DLBCL (P < 0.05). The mean percentage of PCNA positive tumor cells was 52.6. PCNA protein expression was significantly lower in MALT vs. DLBCL (P < 0.0001). There was a significant positive correlation between PCNA score and SPF (P < 0.01, by Spearman analysis). DNA ploidy had no impact on survival in the present study. Both SPF and PCNA expression were important prognostic factors in the univariate analysis; however, in the multivariate analysis, the only independent prognostic factor for survival was PCNA expression. CONCLUSIONS: These findings indicate that SPF and PCNA are significant prognostic factors in patients with primary gastric lymphomas. However, in the present study, DNA ploidy had no impact on survival in patients with primary gastric lymphomas. Copyright 2003 Wiley-Liss, Inc.
机译:背景:DNA倍性,S期分数(SPF)和增殖细胞核抗原(PCNA)被认为是非霍奇金淋巴瘤的重要预后因素。然而,相对缺乏关于其在胃淋巴瘤患者中的预后重要性的报道。方法:本研究回顾性分析了29例原发性胃淋巴瘤患者的上述参数。根据WHO分类,11/29患有B低级粘膜相关淋巴组织淋巴瘤(B-MALT),而18/29患有弥漫性大B细胞淋巴瘤(DLBCL)。通过对PCNA染色研究了增殖活性。此外,通过流式细胞术确定了DNA倍性和SPF的预后意义,并将其与PCNA染色的结果进行了比较。结果:29例患者中有7例患有非整倍性肿瘤。所有非整倍性淋巴瘤的DNA指数值均> 1。 MALT与DLBCL的DNA非整倍性没有差异。 SPF的平均百分比为11.4。发现MALT中的SPF明显低于DLBCL(P <0.05)。 PCNA阳性肿瘤细胞的平均百分比为52.6。与DLBCL相比,MALT中PCNA蛋白表达显着降低(P <0.0001)。 PCNA评分与SPF呈显着正相关(P <0.01,根据Spearman分析)。 DNA倍性对本研究的存活率没有影响。在单变量分析中,SPF和PCNA的表达都是重要的预后因素。然而,在多变量分析中,生存的唯一独立预后因素是PCNA表达。结论:这些发现表明SPF和PCNA是原发性胃淋巴瘤患者的重要预后因素。然而,在本研究中,DNA倍性对原发性胃淋巴瘤患者的存活率没有影响。版权所有2003 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号